Buti M, Casado MA, Calleja JL, Salmerón J, Aguilar J, Rueda M, Esteban R

Long-term treatment with adefovir dipivoxil is more cost-effective than lamivudine for HBeAg-negative patients with chronic hepatitis B

56th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD). San Francisco, California, EEUU. 11-15 nov 2005